Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III StudyDean J Kereiakes, Jonathan M Hill, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology|October 18, 2020
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery DiseaseJonathan M Hill, Dean J Kereiakes, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology|June 20, 2006
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trialAjay J Kirtane, Gregory Piazza, Sabina A Murphy, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 29, 2024
Transcatheter aortic valve replacement achieves similar predicted effective orifice area to surgical aortic valve replacement in bicuspid aortic stenosisJohn E Connolly, Howard C Herrmann, Pavan Atluri, et al.
JACC. Cardiovascular Interventions|November 21, 2024
Coronary Intravascular Lithotripsy for In-Stent Restenosis: The ACC NCDR CathPCI RegistryDean J Kereiakes, Richard A Shlofmitz, Andrew J Klein, et al.
Journal of the American College of Cardiology|November 5, 2013
Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repairD Scott Lim, Matthew R Reynolds, Ted Feldman, et al.
The Journal of Invasive Cardiology|June 26, 2016
New Ventricular Septal Defects Following Balloon-Expandable Transcatheter Aortic Valve ReplacementA Garvey Rene, Dinesh Jagasia, S Rasi Wickramasinghe, et al.
JAMA Cardiology|July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic ReviewKriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
The American Journal of Cardiology|May 29, 2002
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary interventionHoward C Herrmann, Tomasz A Swierkosz, Shiv Kapoor, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III StudyDean J Kereiakes, Jonathan M Hill, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology|October 18, 2020
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery DiseaseJonathan M Hill, Dean J Kereiakes, Richard A Shlofmitz, et al.
Journal of the American College of Cardiology|June 20, 2006
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trialAjay J Kirtane, Gregory Piazza, Sabina A Murphy, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 29, 2024
Transcatheter aortic valve replacement achieves similar predicted effective orifice area to surgical aortic valve replacement in bicuspid aortic stenosisJohn E Connolly, Howard C Herrmann, Pavan Atluri, et al.
JACC. Cardiovascular Interventions|November 21, 2024
Coronary Intravascular Lithotripsy for In-Stent Restenosis: The ACC NCDR CathPCI RegistryDean J Kereiakes, Richard A Shlofmitz, Andrew J Klein, et al.
Journal of the American College of Cardiology|November 5, 2013
Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repairD Scott Lim, Matthew R Reynolds, Ted Feldman, et al.
The Journal of Invasive Cardiology|June 26, 2016
New Ventricular Septal Defects Following Balloon-Expandable Transcatheter Aortic Valve ReplacementA Garvey Rene, Dinesh Jagasia, S Rasi Wickramasinghe, et al.
JAMA Cardiology|July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic ReviewKriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
The American Journal of Cardiology|May 29, 2002
Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary interventionHoward C Herrmann, Tomasz A Swierkosz, Shiv Kapoor, et al.
Circulation|June 12, 2002
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-upMarco Roffi, David J Moliterno, Bernhard Meier, et al.
Pageof 31